ibidi Names the Winners of the 'ibidi Paper Award 2023' Research Prize

18-Sep-2023 - Biotech company ibidi GmbH, located in Gräfelfing, Germany, has just announced the winners of the ibidi Paper Award 2023, an award that honors publications (papers) from up-and-coming researchers that were printed this year in renowned, scientific journals. Max Grönloh, Luise Appeltshauser, and ...

ibidi Awarded With the German bAV Prize 2023

29-Apr-2023 - The Gräfelfing-based biotech company ibidi GmbH received the German bAV Award in Berlin this week. With the 3rd place in the category SME, the insurance and finance industry honored ibidi’s innovative concept of company pension plans. The jury was particularly impressed by its innovation and ...

ibidi Paper Award 2022

Three early career scientists have been recognized by ibidi for their outstanding first author publications in the field of cancer research in 2021

21-Jul-2022 - One PhD student and two postdocs have received the first ibidi Paper Award for successfully publishing their findings in reputable scientific journals. An expert jury, comprised of three renowned international cancer researchers, selected winners from applicants all over the world and rewarded ...

ibidi Awarded with the Export Award Bavaria: Special Edition 2021

02-Dec-2021 - For its excellent crisis strategy during the pandemic, ibidi GmbH has been awarded the Export Award Bavaria 2021: Special Edition 2021, in the category, "Successful Order Processing in Corona Times." The award, which has been presented since 2007 to small- and medium-sized companies that work ...

Start.Smart.Global 2019: ibidi Receives Valuable Funding to Enter the Japanese and Korean Life Science Market

27-Jun-2019 - ibidi has been awarded valuable funding from BioM “Start.Smart.Global” to break into the challenging life science markets of Japan and Korea. They were one of only twelve ambitious European companies selected, which plan on expanding into these two Asian markets in 2020. The funding includes a ...

ibidi has been chosen as a finalist for the German Economy Innovation Award 2012/13

21-Dec-2012 - Out of 275 applicants, ibidi has been selected as one of the 20 finalists, and is now competing against four other companies for the top prize in the “Medium-Sized Business” category. The first-round selection was made by a scientific committee, with representatives from German economic and ...

Fast 50 Technology Germany - ibidi Awarded for the 4th Consecutive Year

12-Nov-2012 - ibidi GmbH was awarded again this year by the Fast 50 competition!For the forth year in a row, ibidi has received an award from the “Deloitte Technology Fast 50” competition. The Fast 50 is an awards program that honours companies that demonstrate exceptional business growth, technological ...

Max Planck Innovation awards license for actin marker LifeAct

Max Planck Innovation and ibidi sign license agreement for cytoskeleton research

28-Jul-2010 - Max Planck Innovation GmbH, the technology transfer organization of the Max Planck Society, has awarded an exclusive license for LifeAct to ibidi GmbH, a provider of cell analysis products, located in Martinsried near Munich. The novel peptide allows for actin, an important protein, to be made ...

ibidi establishes partnership with Seahorse Bioscience

05-Feb-2009 - ibidi GmbH announced a partnership with Seahorse Bioscience, Inc. of Billerica; Main, USA. Under the terms of the agreement ibidi will exclusively distribute the products of Seahorse Bioscience in Germany and Austria. With this partnership ibidi further strengthens its position as a service ...